Latest Stock Split Details
Key information about Cadrenal Therapeutics, Inc. Common Stock's most recent stock split
Split Date: 2024-08-20
Split Ratio: 1:15
Price Before Split: $0.48
Price After Split: $0.03
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 15.00 times fewer shares (a 1:15 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Cadrenal Therapeutics, Inc. Common Stock's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-08-20 | 1:15 | Yes | $0.48 | $0.03 |
About Cadrenal Therapeutics, Inc. Common Stock
Company overview and industry information
Cadrenal Therapeutics, Inc. Common Stock (CVKD) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Cadrenal Therapeutics, Inc. Common Stock Summary